ArticleAnnals of surgical oncology2025

ASO Author Reflections: Optimizing Treatment for Resectable Pancreatic Cancer: CA19-9 > 500 U/mL as a Biologic Indicator for Neoadjuvant Therapy.

Kojiro Omiya et al.PubMed ↗Publisher ↗

No numbers read from the abstract.